CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 5,800 shares at $45.51 ($263,970)
- 4 Grant or award Chief Financial Officer acquired 10,303 shares (grant or award)
- 4 Open-market buy CEO bought 25,000 shares at $46.27 ($1,156,800)
- 4 Open-market sale CEO sold 1,262 shares at $66.65 ($84,112)
- 4 Open-market sale Chief Financial Officer sold 1,568 shares at $78.27 ($122,727)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP/Chief Scientific Officer sold 10,000 shares at an average $63.22 ($632,156)
- 4 Open-market sale EVP/Chief Scientific Officer sold 10,000 shares at $45.00 ($450,000)
- 4 Open-market sale EVP/Chief Scientific Officer sold 20,000 shares at $40.02 ($800,400)
- 4 Grant or award EVP/Chief Medical Officer acquired 20,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP/Chief Scientific Officer sold 228 shares at $31.21 ($7,116)
- 4 Open-market sale EVP/Chief Scientific Officer sold 3,000 shares at $31.39 ($94,170)
- 4 Open-market sale CEO sold 1,976 shares at $36.66 ($72,440)
- 4 Open-market sale EVP/Chief Scientific Officer sold 10,000 shares at $35.29 ($352,900)
- 4 Open-market sale EVP/Chief Scientific Officer sold 10,238 shares at an average $37.41 ($383,028)
- 4 Open-market sale EVP/Chief Scientific Officer sold 3,000 shares at $32.22 ($96,660)
Page 9 of 18 · 351 filings